Human–Pig Chimeric Organ in Organ Transplantation from Islamic Bioethics Perspectives

IF 1.3 Q3 ETHICS

Asian Bioethics Review Pub Date : 2022-11-16 DOI:10.1007/s41649-022-00233-2

Muhammad Faiq Mohd Zailani, Mohammad Naqib Hamdan, Aimi Nadia Mohd Yusof

引用次数: 1

Abstract

The use of pig derivatives in medicine is forbidden in Islamic law texts, despite the fact that certain applications offer medical advantages. Pigs can be one of the best human organ hosts; therefore, using human–pig chimeras may generate beneficial impact in organ transplantation, particularly in xenotransplantation. In Islam, medical emergencies may allow some pig-based treatments and medical procedures to be employed therapeutically. However, depending on the sort of medical use, emergency situation might differ. Using Islamic legal maxim as bioethical framework, the purpose of this study is to examine the use of pigs for the purpose of human–pig chimeric transplant from the perspective of Islamic bioethics. According to the findings, chimeric organ transplantation using pigs should only be done in emergency situations.

查看原文本刊更多论文

从伊斯兰生物伦理学角度看器官移植中的人猪嵌合器官

尽管某些应用具有医疗优势，但伊斯兰法律文本禁止在医学中使用猪衍生物。猪可能是最好的人体器官宿主之一；因此，使用人-猪嵌合体可能在器官移植，特别是异种移植中产生有益的影响。在伊斯兰教中，医疗紧急情况可能允许一些以猪为基础的治疗和医疗程序用于治疗。然而，根据医疗用途的不同，紧急情况可能会有所不同。本研究以伊斯兰法律格言为生物伦理框架，从伊斯兰生物伦理的角度考察猪用于人猪嵌合移植的情况。根据研究结果，只有在紧急情况下才能使用猪进行嵌合器官移植。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Asian Bioethics Review Multiple-

CiteScore

6.20

自引率

3.40%

发文量

期刊介绍： Asian Bioethics Review (ABR) is an international academic journal, based in Asia, providing a forum to express and exchange original ideas on all aspects of bioethics, especially those relevant to the region. Published quarterly, the journal seeks to promote collaborative research among scholars in Asia or with an interest in Asia, as well as multi-cultural and multi-disciplinary bioethical studies more generally. It will appeal to all working on bioethical issues in biomedicine, healthcare, caregiving and patient support, genetics, law and governance, health systems and policy, science studies and research. ABR provides analyses, perspectives and insights into new approaches in bioethics, recent changes in biomedical law and policy, developments in capacity building and professional training, and voices or essays from a student’s perspective. The journal includes articles, research studies, target articles, case evaluations and commentaries. It also publishes book reviews and correspondence to the editor. ABR welcomes original papers from all countries, particularly those that relate to Asia. ABR is the flagship publication of the Centre for Biomedical Ethics, Yong Loo Lin School of Medicine, National University of Singapore. The Centre for Biomedical Ethics is a collaborating centre on bioethics of the World Health Organization.